Urinary 17-Ketosteroids in Women with Breast Cancer
Author Information
Author(s): A. W. Sum, R. Hobkirk, Helen J. Stewart, D. W. Blair, A. P. M. Forrest
Primary Institution: University Department of Surgery, Western Infirmary, Glasgow
Hypothesis
The study investigates the levels of urinary 17-ketosteroids in women with advanced breast cancer treated by endocrine surgery.
Conclusion
The study found that adrenalectomy and oophorectomy significantly reduced urinary 17-ketosteroid levels, but the presence of these steroids post-surgery did not correlate with clinical response.
Supporting Evidence
- Six of the twelve patients had objective evidence of regression of cancer following adrenalectomy.
- Adrenalectomy and oophorectomy led to a significant decrease in urinary 17-ketosteroids.
- Post-operative levels of 11-oxy 17-ketosteroids were present in patients receiving maintenance cortisone.
Takeaway
Doctors looked at urine samples from women with breast cancer to see how surgery affected certain hormones, and they found that surgery lowered these hormones, but it didn't always help the cancer get better.
Methodology
Urinary 17-ketosteroids were estimated in women with metastatic or recurrent mammary cancer treated by oophorectomy, adrenalectomy, or pituitary implantation, using chromatography and colorimetric methods.
Limitations
The study did not find a significant relationship between pre-operative steroid levels and clinical response to surgery.
Participant Demographics
The study involved post-menopausal women with advanced breast cancer.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website